secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2024-10-09T23:59:59+00:00
Accession:  0001193125-24-235251
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex receives Nasdaq delisting notice for failing equity standard; will appeal
--------------------------------------------------------------------------------

- Company failed to meet Nasdaq's minimum $2.5M stockholders' equity requirement for continued listing.
- Nasdaq granted extension until Sept 30, 2024, to regain compliance; company did not comply.
- On Oct 7, 2024, Nasdaq determined to delist unless company timely appeals to a Hearings Panel.
- Company intends to appeal, which automatically stays suspension and delisting pending Panel decision.
- No assurance that Hearings Panel will grant continued listing or that compliance will be achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524235251/0001193125-24-235251-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524235251/d851320d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-235251

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer